NCT07150026View on ClinicalTrials.gov

An Exploratory Evaluation of the Safety and Efficacy of Vorinostat in Pitt Hopkins Syndrome

PHASE1Not yet recruitingINTERVENTIONAL

Enrollment

5

Participants

Timeline

Start Date

October 15, 2025

Primary Completion Date

July 15, 2026

Study Completion Date

October 15, 2026

Conditions

Pitt Hopkins Syndrome

Interventions

DRUG

Vorinostat (SAHA)

oral suspension

DRUG

Placebo

placebo

Trial Locations (1)

Unknown

Grupo de Investigación Clínica PECET (GIC-PECET), Medellín

All Listed Sponsors

lead

Unravel Biosciences, Inc.

INDUSTRY